Direkt zum Inhalt
Merck
  • Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation.

Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation.

The Journal of surgical research (2013-05-28)
Ilhan Inci, Sven Hillinger, Stephan Arni, Tevfik Kaplan, Demet Inci, Walter Weder
ZUSAMMENFASSUNG

We tested whether an injured lung graft from category-3 donation after cardiac death donor could be reconditioned with an ex vivo lung perfusion (EVLP) system by intrabronchial diluted surfactant lavage before transplantation. In a pig model, cardiac arrest was induced by deconnecting from the ventilator. Left lung injury was done by intrabronchial instillation of 1 mL/kg pepsin + HCl. After retrieval, the heart-lung block was stored at 4°C for 2 h. In the treated group, transplantation was performed after reconditioning with intrabronchial diluted surfactant lavage in EVLP system. During EVLP, surfactant group showed better oxygenation and lower pulmonary vascular resistance. After transplantation, better oxygenation, lower mean pulmonary artery pressure, and lower lung edema were observed in surfactant group. Lower blood IL-1 beta and IL-6 cytokine levels were measured in the surfactant group. In bronchoalveolar lavage, the percentage of neutrophils, IL-1 beta and IL-6 cytokine levels, amount of protein, and neutrophil infiltration in the lung tissue at the end of the experiment were significantly lower in the surfactant group. Our data demonstrate the feasibility of reconditioning and transplantation of an acutely damaged lung graft due to aspiration from a category-3 DCD donor. Implementation of an EVLP system is an efficacious tool to recondition and assess a questionable graft before transplantation.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Salzsäure, ACS reagent, 37%
Sigma-Aldrich
Salzsäure, ACS reagent, 37%
Sigma-Aldrich
Chlorwasserstoff -Lösung, 4.0 M in dioxane
Sigma-Aldrich
Pepsin aus Schweinemagenschleimhaut, powder, ≥250 units/mg solid
Sigma-Aldrich
Salzsäure -Lösung, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Pepsin aus Schweinemagenschleimhaut, lyophilized powder, ≥3,200 units/mg protein
Sigma-Aldrich
Salzsäure, meets analytical specification of Ph. Eur., BP, NF, fuming, 36.5-38%
Sigma-Aldrich
Salzsäure, 37 wt. % in H2O, 99.999% trace metals basis
Sigma-Aldrich
Chlorwasserstoff -Lösung, 2.0 M in diethyl ether
Sigma-Aldrich
Salzsäure, 36.5-38.0%, BioReagent, Molecular Biology
Sigma-Aldrich
Pepsin aus Schweinemagenschleimhaut, powder, ≥400 units/mg protein
Supelco
Salzsäure -Lösung, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
Chlorwasserstoff -Lösung, 1.0 M in diethyl ether
Sigma-Aldrich
Salzsäure -Lösung, ~6 M in H2O, for amino acid analysis
Sigma-Aldrich
Chlorwasserstoff, ReagentPlus®, ≥99%
Sigma-Aldrich
Chlorwasserstoff -Lösung, 3 M in cyclopentyl methyl ether (CPME)
Sigma-Aldrich
Salzsäure -Lösung, 32 wt. % in H2O, FCC
Sigma-Aldrich
Pepsin aus Schweinemagenschleimhaut, powder, slightly beige, ≥500 U/mg
Sigma-Aldrich
Pepsin aus Schweinemagenschleimhaut, powder, slightly beige, 1200-2400 U/mg
Sigma-Aldrich
Chlorwasserstoff -Lösung, 1.0 M in acetic acid
Supelco
Hydrogen chloride – ethanol, ~1.25 M HCl, derivatization grade (GC derivatization), LiChropur
Sigma-Aldrich
Pepsin aus Schweinemagenschleimhaut, tested according to Ph. Eur.
Sigma-Aldrich
Pepsin−Agarose from porcine gastric mucosa, lyophilized powder, ≥30 units/mg dry solid
Supelco
Chlorwasserstoff-1-butanol -Lösung, ~3 M in 1-butanol, derivatization grade (GC derivatization), LiChropur
Sigma-Aldrich
Pepsin aus Schweinemagenschleimhaut, Suitable for manufacturing of diagnostic kits and reagents, lyophilized powder, ≥3200 units/mg protein